Table 2.
Summarized results
| Patient | Follow up period (months) | Early complication | Late complication | Satisafction mark | |
|---|---|---|---|---|---|
| M.M | 46 | / | / | 5 | Zero reccurence |
| L.J. | 44 | / | / | 5 | |
| A.J | 42 | / | / | 5 | |
| C.K. | 40 | / | / | 5 | |
| I.G. | 40 | Seroma | skin irregularity | 4 | |
| T.T. | 37 | Seroma | / | 5 | |
| S.Z. | 32 | / | / | 5 | |
| Z.A. | 32 | / | / | 5 | |
| S.A. | 27 | / | / | 5 | |
| V.V. | 25 | / | / | 5 | |
| M.Z. | 21 | / | indentation | 5 | |
| N.D. | 20 | / | / | 4 | |
| S.J. | 19 | / | / | 5 | |
| J.N. | 18 | / | skin irregularity | 4 | |
| V.M. | 18 | / | / | ||
| Lj.D. | 18 | / | / | 5 | |
| B.N. | 16 | / | / | 5 | |
| F.B. | 15 | / | / | 5 | |
| M.S. | 15 | / | skin irregularity indentation | 3 | |
| M.A. | 14 | / | / | 5 | |
| O.S. | 13 | / | / | 5 | |
| C.S. | 12 | / | / | 5 |